−4.54MXN
−1.07 BMXN
102.52 MMXN
250.87 M
About OCUGEN INC
Sector
CEO
Shankar Musunuri
Headquarters
Malvern
Website
Employees (FY)
65
Founded
2013
ISIN
US67577C1053
FIGI
BBG010JC9458
Ocugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. Its product pipeline candidates include OCU400, OCU410, OCU200, and COVAXIN. The firm's modifier gene therapy platform is engaged in addressing retinal diseases, including retinitis pigmentosa, leber congenital amaurosis, and dry age-related macular degeneration. The company was founded by Shankar Musunuri and Uday B. Kompella in 2013 and is headquartered in Malvern, PA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of OCGN is 23.90 MXN — it has decreased by 8.08% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange OCUGEN INC stocks are traded under the ticker OCGN.
OCUGEN INC is going to release the next earnings report on May 3, 2024. Keep track of upcoming events with our Earnings Calendar.
OCGN stock is 8.79% volatile and has beta coefficient of 1.06. Check out the list of the most volatile stocks — is OCUGEN INC there?
One year price forecast for OCUGEN INC has a max estimate of 132.19 MXN and a min estimate of 115.66 MXN.
OCGN earnings for the last quarter are −1.05 MXN whereas the estimation was −1.22 MXN which accounts for 14.29% surprise. Estimated earnings for the next quarter are −1.02 MXN. See more details about OCUGEN INC earnings.
OCUGEN INC revenue for the last quarter amounts to 0 MXN despite the estimated figure of 0 MXN. In the next quarter revenue is expected to reach 42.26 M MXN.
Yes, you can track OCUGEN INC financials in yearly and quarterly reports right on TradingView.
OCGN stock has fallen by 17.59% compared to the previous week, the month change is a 33.07% rise, over the last year OCUGEN INC has showed a 59.33% increase.
OCGN net income for the last quarter is −186.33 M MXN, while the quarter before that showed −246.85 M MXN of net income which accounts for 24.52% change. Track more OCUGEN INC financial stats to get the full picture.
Today OCUGEN INC has the market capitalization of 6.33 B, it has increased by 34.34% over the last week.
No, OCGN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, OCGN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OCUGEN INC stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 65.00 employees. See our rating of the largest employees — is OCUGEN INC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So OCUGEN INC technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating OCUGEN INC stock shows the neutral signal. See more of OCUGEN INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on OCUGEN INC future price: according to them, OCGN price has a max estimate of 132.19 MXN and a min estimate of 115.66 MXN. Read a more detailed OCUGEN INC forecast: see what analysts think of OCUGEN INC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. OCUGEN INC EBITDA is −1.15 B MXN, and current EBITDA margin is −1.07 K%. See more stats in OCUGEN INC financial statements.